News for Industry

(Rancho Cordova, CA) Cesca Inc. successfully secured a contract to provide cell storage, processing and consumables platform to upstate medical University’s public cord blood bank.

(Marietta, GA) MiMedx group Inc. is a leading regenerative medicine company utilizing human amniotic tissue reported record revenue for the 3^rd quarter of 2014.

(Sunrise, FL) Bioheart, Inc released twelve-month data from its phase 1 ANGEL trial which is being conducted in Mexico.

(Boston, MA) A petri dish with human brain cells that develop structures specific for Alzheimer’s disease, opening the door for potential drug therapy.

(Cambridge, MA) Researchers identify 3 physical characteristics of mesenchymal stem cells that can distinguish them from other immature cells found in bone marrow.

(San Francisco, CA) The California Institute for Regenerative Medicine (CIRM) awarded $60 million to researchers hoping to accelerate the development of a treatment for type I diabetes.

(Tokyo, Japan) The non-life insurance companies in Japan will begin to sell policies to cover the cultivation of stem cells for regenerative medicine procedures.

(San Francisco, CA)  The University of California, San Francisco announced that it has entered into an exclusive license agreement with Accurexa, Inc for global licensing of a medical stereotactic device.

(Alameda, CA) BioTime Inc. completed a series of extensive preclinical safety and efficacy studies for its product OpRegen intended for treatment of dry age-related macular degeneration.